MedTech News
.................... by Andrew Celentano
Scopio Labs Secures EU IVDR Certification for the Industry-Only Full-Field Digital Bone Marrow Application
PARSIPPANY, N.J., April 14, 2026 /PRNewswire/ — Scopio Labs, the leader in Full-Field digital cell morphology, today announced it has achieved IVDR certification for its Full-Field Bone Marrow Aspirate (FF-BMA) Application.
Reach Surgical Receives CE Mark Approval for iREACH IRIS, First Powered Reusable Stapler with Real-Time Firing Curve™ and 90° Articulation
SINGAPORE, April 15, 2026 /PRNewswire/ — Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for iREACH IRIS, a next-generation powered stapling platform designed to deliver Real-Time Firing CurveTM and up to 90° articulation during surgery.
A Single DNA Letter Change Can Trigger Female Mice to Develop Testes
A new study suggests a simple letter change can reverse sex development, causing a mouse with female chromosomes (XX) to develop male genitalia.
Travere’s Filspari overcomes Phase 3 fail to become first drug for rare kidney disease
The FDA has greenlit Travere Therapeutics’ Filspari as the only available treatment for focal segmental glomerulosclerosis despite the drug’s loss to Sanofi’s Avapro in a Phase 3 study.
New drug doubles one-year survival in pancreatic cancer trial
Phase 2 randomized trial shows 38% reduction in risk of death with the drug when combined with chemotherapy
Protaryx earns FDA nod for transseptal puncture device
Protaryx Medical announced that it received FDA 510(k) clearance for its proprietary Transseptal Puncture Device.
Smart OLED patch uses light to automate drug delivery, doubling healing speed
A research team has developed a “self-regulating OLED wound healing patch” that combines light and drugs to pull up the wound recovery speed by about twice.
Simple procedure relieves painful complications after deep vein thrombosis
A major multi-site clinical trial co-led by researchers at Washington University School of Medicine in St. Louis has shown that post-thrombotic syndrome—a common and often painful complication suffered by many people who have experienced blockages of major veins due to blood clots—can be effectively treated with a minimally invasive procedure.